1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow AdvanceCor GmbH: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Pharmacokinetic and -Dynamic Study of PR-15, an Inhibitor of Platelet Adhesion revacept (PR-15) - Thrombosis, Acute Coronary Syndrome | Phase 1 | Completed | AdvanceCor GmbH | 30 | 2006-03-01 | 2012-10-19 |
Acute Coronary Syndrome (1) · Myocardial Infarction (1) · Stroke (1) · Thrombosis (1)
Revacept (1)
Germany (1)